Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| XBiotech Inc.XBIT · Entity 7044 | 10% owner | February 12, 2020 | March 05, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
XBiotech Inc.
Report date February 12, 2020 · Filed March 05, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,914,111 |
Reported balance
After 2020-02-12 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2020-02-12 · Disposition to issuer · Disposed 1,949,929 · Balance 3,914,111 F1: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. F2: The Form 4/A filed on February 19, 2019 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock.
F2: The Form 4/A filed on February 19, 2019 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2020 Filed Feb 14, 2020 15:05 UTC | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 1,868,870 | $30.00 | $56,066,100.00 |
DisclosureSEC source: 0001104659-20-021546 · tm208173d1_form4.xml · nonDerivative · entry 1 GUT THOMAS · CIK 0001640283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,995,170 F1 · shares: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. The number of shares reported is an estimate, and will be amended when a final determination is made. Read SEC document |
| February 12, 2020 Filed Feb 19, 2020 18:04 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 1,947,584 | $30.00 | $58,427,520.00 |
DisclosureSEC source: 0001104659-20-022929 · tm209304-1_form4a.xml · nonDerivative · entry 1 GUT THOMAS · CIK 0001640283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,916,456 F1 · shares: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. Read SEC document |
| February 12, 2020 Filed Mar 5, 2020 11:32 UTC Amendment | XBiotech Inc. XBIT · Entity 7044 | Disposition to issuerCommon Stock | 1,949,929 | $30.00 | $58,497,870.00 |
DisclosureSEC source: 0001104659-20-029536 · tm2011767d1_form4a.xml · nonDerivative · entry 1 GUT THOMAS · CIK 0001640283 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,914,111 F1 · shares: Represents shares of common stock tendered by the reporting person and accepted for payment and purchased by the issuer in the issuer's tender offer for up to $420 million of its common stock. F2 · shares: The Form 4/A filed on February 19, 2019 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of common stock. F2 · balance_after: The Form 4/A filed on February 19, 2019 is amended by this Form 4 amendment to correctly reflect the reporting person's ownership of common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.